Accustem Sciences Inc. - 10-Q Filing
Accustem Sciences reports $1.87M net loss for Q3 2026 driven by $1.5M in acquired in-process R&D expense.
Tickers: $ACUT
Read the full article at SEC EDGAR
Part of the story NON INVASIVE MONITORING SYSTEMS INC /FL/ - 10-Q Filing (2 articles)